Moneycontrol PRO
HomeNewsStridespharmascience

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Strides Arcolab, target Rs 1295: Manish Hathiramani

    Manish Hathiramani of Deen Dayal Investments recommends buying Strides Arcolab with a target of Rs 1295.

  • Go long in Strides Arcolab, says Kunal Saraogi

    Kunal Saraogi, CEO at Equityrush recommends going long in Strides Arcolab with a target of Rs 1220.

  • Buy Strides Arcolab, says Sudarshan Sukhani

    According to Sudarshan Sukhani of s2analytics.com, one can buy Strides Arcolab as the stock may rally.

  • Go long in Aurobindo Pharma: Manas Jaiswal

    Manas Jaiswal of manasjaiswal.com recommends going long in Aurobindo Pharma with a target of Rs 1250.

  • Hold Strides Arcolab: Shahina Mukadam

    Shahina Mukadam, market expert is of the view that one may hold Strides Arcolab.

  • Remain invested in Strides Arcolab: Kunal Bothra

    Kunal Bothra, Head of Advisory at LKP Securities is of the view that one may remain invested in Strides Arcolab.

  • Focus on midcap pharma space: Gautam Trivedi

    Gautam Trivedi, MD & CEO of Religare Capital Markets is of the view that one may focus on midcap pharma space.

  • Strides Arcolab may test Rs 1150-1200: Kunal Bothra

    Kunal Bothra of LKP Securities is of the view that Strides Arcolab may test Rs 1150-1200.

  • Strides Arcolab may test Rs 1000, says Kunal Saraogi

    Kunal Saraogi of Equityrush is of the view that Strides Arcolab may test Rs 1000.

  • Buy Tata Motors DVR, HPCL, Strides Acrolab: Gaurav Bissa

    Gaurav Bissa of LKP Securities recommends buying Tata Motors (DVR), HPCL and Strides Acrolab.

  • Buy Strides Arcolab, Siemens: Gaurav Bissa

    Gaurav Bissa of LKP Securities advises buying Strides Arcolab, Power Finance Corporation and Siemens.

  • Prefer Wockhardt, Strides Arcolab: Gaurav Bissa

    Gaurav Bissa, Derivatives Analyst at LKP Securities prefers Wockhardt and Strides Arcolab from the midcap pharma space.

  • Buy BHEL, Strides Arcolab: Manas Jaiswal

    Manas Jaiswal of manasjaiswal.com advises buying Strides Arcolab and BHEL.

  • Prefer Strides Arcolab, says Rahul Arora

    Rahul Arora, CEO at Nirmal Bang Institutional Equities prefers Strides Arcolab.

  • Buy Strides Arcolab, LIC Housing, OBC: Kunal Saraogi

    Kunal Saraogi of Equityrush is of the view that one can buy Oriental Bank of Commerce for a target price of Rs 312 and Shriram Transport Finance Corporation for a target price of Rs 1105.

  • Bull's Eye: Buy DCB Bank, LIC Housing, OBC, Berger Paints

    Kunal Saraogi of Equityrush recommends buying LIC Housing Finance for a target price of Rs 430 and Oriental Bank of Commerce for a target price of Rs 312.

  • Hold Strides Arcolab, says Hemen Kapadia

    Hemen Kapadia, VP at KR Choksey Securities advises holding Strides Arcolab.

  • Stay invested in Strides Arcolab: Jagannadham Thununguntla

    According to Jagannadham Thununguntla, Head of Research at SMC Global Securities, one may stay invested in Strides Arcolab.

  • Bull's Eye: Buy Reliance Cap, Ashok Leyland, Shasun Pharma

    Kunal Saraogi, Equityrush advises buying Jain Irrigation for a target price of Rs 83 and Ashok Leyland for a target price of Rs 46.

  • Buy Strides, Navneet; sell IFCI: Krish Subramanium

    Krish Subramanium of Asit C Mehta Investment Intermediates recommends selling Hindustan Zinc for a target price of Rs 147 and IFCI for a target price of Rs 32.

  • Buy Strides Arcolab, Mindtree: Akshata Deshmukh

    Akshata Deshmukh of Networth Capital is of the view that SKS Microfinance can test Rs 305 and Oriental Bank of Commerce can test Rs 237.

  • Bull's Eye: Buy Strides Arcolab, Navneet; short UCO Bank

    Akshata Deshmukh, Networth Stock Broking advises buying Strides Acrolab for a target price of Rs 790 and Mindtree for a target price of Rs 1,088.

  • Buy Strides Acrolab, advises Pritesh Mehta

    Pritesh Mehta, Senior Technical Analyst at IIFL recommends buying Strides Arcolab for a target of Rs 750.

  • Sell Strides Arcolab: SP Tulsian

    SP Tulsian of sptulsian.com is of the view that one may sell Strides Arcolab.

  • Hold Strides Arcolabs: Kunal Bothra

    Kunal Bothra, head of Advisory at LKP is of the view that one may hold on to Strides Arcolabs.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347